Oral etoposide for patients with advanced adenocarcinoma of the pancreas

被引：0
|
作者：
Eva Thomas
Pamela Dumas
Jaffer A. Ajani
机构：
[1] University of Texas M.D. Anderson Cancer Center,Departments of Gastrointestinal Oncology and Surgical Oncology
来源：
Investigational New Drugs | 1998年 / 16卷
关键词：
adenocarcinoma; pancreas; oral etoposide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose: Oral etoposide has been shown to be effective against some solid tumor types. This phase II study examined the efficacy of oral etoposide in patients with untreated advanced adenocarcinoma of the pancreas.
引用
收藏
页码：333 / 335
页数：2
相关论文
共 50 条
  • [21] Intraperitoneal gemcitabine therapy for advanced adenocarcinoma of the pancreas
    T. C. Gamblin
    M. J. Egorin
    E. G. Zuhowski
    T. F. Lagattuta
    L. L. Herscher
    A. Russo
    H. R. Alexander
    R. L. Dedrick
    D. L. Bartlett
    Annals of Surgical Oncology, 2004, 11 : S55 - S55
  • [22] Patients with Advanced Ovarian Cancer Administered Oral Etoposide following Taxane as Maintenance Chemotherapy
    Nagano, Hiroaki
    Tachibana, Yasunari
    Kawakami, Megumi
    Ueno, Mariko
    Morita, Yoshihiro
    Muraoka, Mitsue
    Takagi, Koichiro
    CASE REPORTS IN ONCOLOGY, 2016, 9 (01): : 195 - 204
  • [23] PHASE-II STUDY OF ORAL ETOPOSIDE FOR PATIENTS WITH ADVANCED BREAST-CANCER
    ATIENZA, DM
    VOGEL, CL
    TROCK, B
    SWAIN, SM
    CANCER, 1995, 76 (12) : 2485 - 2490
  • [24] CARBOPLATIN AND ORAL ETOPOSIDE IN THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CANCER REFRACTORY TO ANTHRACYCLINES
    FOUNTZILAS, G
    SKARLOS, D
    THEOHARIS, D
    GIANNAKAKIS, T
    STATHOPOULOS, G
    TUMORI, 1993, 79 (06) : 389 - 392
  • [25] Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer
    Asamoto, H
    Kawahara, M
    Iwami, F
    Kuba, M
    Furuse, K
    Tamura, T
    Saijo, N
    Shimoyama, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (12) : 745 - 748
  • [26] Phase I trial of oral etoposide in combination with celecoxib in patients with advanced malignancies.
    Luu, TH
    Twardowski, P
    Leong, L
    Lim, D
    Morgan, R
    McNamara, M
    Portnow, J
    Ruel, C
    Shibata, S
    Synold, T
    Doroshow, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 241S - 241S
  • [27] Dose-escalation study of oral etoposide and carboplatin in patients with advanced lung cancer
    Atagi, S
    Furuse, K
    Kawahara, M
    Kodama, N
    Ogawara, M
    Kubota, K
    Matsui, K
    Kusunoki, Y
    Masuda, N
    Takada, M
    Negoro, S
    Fukuoka, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1996, 26 (05) : 316 - 321
  • [28] Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinoma
    Mackler, Niklas J.
    Pienta, Kenneth J.
    Dunn, Rodney L.
    Cooney, Kathleen A.
    Redman, Bruce G.
    Olson, Karin B.
    Fardig, Judith E.
    Smith, David C.
    CLINICAL GENITOURINARY CANCER, 2007, 5 (05) : 318 - 322
  • [29] CHRONIC ORAL ETOPOSIDE IN ADVANCED BREAST-CANCER
    PALOMBO, H
    ESTAPE, J
    VINOLAS, N
    GRAU, JJ
    MANE, JM
    DANIELS, M
    MELLADO, B
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 33 (06) : 527 - 529
  • [30] PROLONGED ORAL ETOPOSIDE FOR REFRACTORY ADVANCED UTERINE LEIOMYOSARCOMA
    CHANTARAWIROJ, P
    TRESUKOSOL, D
    KUDELKA, AP
    EDWARDS, CL
    SILVA, EG
    WHARTON, JT
    KAVANAGH, JJ
    GYNECOLOGIC ONCOLOGY, 1995, 58 (02) : 248 - 250
12345